Literature DB >> 16472774

Oxidative stress promotes mutant huntingtin aggregation and mutant huntingtin-dependent cell death by mimicking proteasomal malfunction.

Anand Goswami1, Priyanka Dikshit, Amit Mishra, Shalaka Mulherkar, Nobuyuki Nukina, Nihar Ranjan Jana.   

Abstract

Huntington's disease (HD) is a familial neurodegenerative disorder caused by an abnormal expansion of CAG repeats in the coding region of huntingtin gene. A major hallmark of HD is the proteolytic production of N-terminal fragments of huntingtin containing polyglutamine repeats that form ubiquitinated aggregates in the nucleus and cytoplasm of the affected neurons. However, the mechanism by which the mutant huntingtin causes neurodegeneration is not well understood. Here, we found that oxidative stimuli enhance the polyglutamine-expanded truncated N-terminal huntingtin (mutant huntingtin) aggregation and mutant huntingtin-induced cell death. Oxidative stimuli also lead to rapid proteasomal dysfunction in the mutant huntingtin expressing cells as compared to normal glutamine repeat expressing cells. Overexpression of Cu/Zn superoxide dismutase (SOD1), Hsp40 or Hsp70 reverses the oxidative stress-induced proteasomal malfunction, mutant huntingtin aggregation, and death of the mutant huntingtin expressing cells. Finally, we show the higher levels of expression of SOD1 and DJ-1 in the mutant huntingtin expressing cells. Our result suggests that oxidative stress-induced proteasomal malfunction might be linked with mutant huntingtin-induced cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472774     DOI: 10.1016/j.bbrc.2006.01.136

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  Large putative PEST-like sequence motif at the carboxyl tail of human calcium receptor directs lysosomal degradation and regulates cell surface receptor level.

Authors:  Xiaolei Zhuang; John K Northup; Kausik Ray
Journal:  J Biol Chem       Date:  2011-12-12       Impact factor: 5.157

2.  Identification and Microbial Production of the Raspberry Phenol Salidroside that Is Active against Huntington's Disease.

Authors:  Nicolai Kallscheuer; Regina Menezes; Alexandre Foito; Marcelo Henriques da Silva; Adelaide Braga; Wijbrand Dekker; David Méndez Sevillano; Rita Rosado-Ramos; Carolina Jardim; Joana Oliveira; Patrícia Ferreira; Isabel Rocha; Ana Rita Silva; Márcio Sousa; J William Allwood; Michael Bott; Nuno Faria; Derek Stewart; Marcel Ottens; Michael Naesby; Cláudia Nunes Dos Santos; Jan Marienhagen
Journal:  Plant Physiol       Date:  2018-11-05       Impact factor: 8.340

3.  Sulforaphane enhances proteasomal and autophagic activities in mice and is a potential therapeutic reagent for Huntington's disease.

Authors:  Yanying Liu; Casey L Hettinger; Dong Zhang; Khosrow Rezvani; Xuejun Wang; Hongmin Wang
Journal:  J Neurochem       Date:  2014-01-18       Impact factor: 5.372

4.  Dopamine D₂/D₃ agonists with potent iron chelation, antioxidant and neuroprotective properties: potential implication in symptomatic and neuroprotective treatment of Parkinson's disease.

Authors:  Sanjib Gogoi; Tamara Antonio; Subramanian Rajagopalan; Maarten Reith; Julie Andersen; Aloke K Dutta
Journal:  ChemMedChem       Date:  2011-05-12       Impact factor: 3.466

Review 5.  Metabolism in HD: still a relevant mechanism?

Authors:  Wenzhen Duan; Mali Jiang; Jing Jin
Journal:  Mov Disord       Date:  2014-08-13       Impact factor: 10.338

6.  Discovery of 4-(4-(2-((5-Hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and as iron chelator: in vivo activity indicates potential application in symptomatic and neuroprotective therapy for Parkinson's disease.

Authors:  Balaram Ghosh; Tamara Antonio; Maarten E A Reith; Aloke K Dutta
Journal:  J Med Chem       Date:  2010-03-11       Impact factor: 7.446

7.  Genome-wide RNAi screen and in vivo protein aggregation reporters identify degradation of damaged proteins as an essential hypertonic stress response.

Authors:  Keith P Choe; Kevin Strange
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-01       Impact factor: 4.249

8.  Oxidative stress and plasma aminopeptidase activity in Huntington's disease.

Authors:  Raquel Duran; Francisco J Barrero; Blas Morales; Juan D Luna; Manuel Ramirez; Francisco Vives
Journal:  J Neural Transm (Vienna)       Date:  2010-01-22       Impact factor: 3.575

Review 9.  Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Authors:  Sylvette Ayala-Peña
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

10.  Puromycin-based vectors promote a ROS-dependent recruitment of PML to nuclear inclusions enriched with HSP70 and Proteasomes.

Authors:  Diarmuid M Moran; Hong Shen; Carl G Maki
Journal:  BMC Cell Biol       Date:  2009-05-01       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.